The Israel Medical Association journal : IMAJ · 2003
Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lev Dorit, Binson Inga, Foldes A Joseph, Watemberg Nathan, Lerman-Sagie Tally
Аннотация
BACKGROUND: The osteoporosis-pseudoglioma syndrome is a rare autosomal recessive disorder characterized by severe juvenile-onset osteoporosis and congenital or early-onset blindness. Other manifestations include muscular hypotonia, ligamentous laxity, mild mental retardation and seizures. The gene responsible was recently identified to be the low density lipoprotein receptor-related family member LRP5 on chromosome 11q11-12.
OBJECTIVE: To measure bone density in two siblings with the OPPG syndrome as well as in their family members (parents and siblings).
METHODS: Bone mineral density was determined in the lumbar spine (antero-posterior), femoral neck, two-thirds distal forearm (> 95% cortical bone) and ultradistal forearm (predominantly trabecular bone) by dual-energy X-ray absorptiometry.
RESULTS: The studies revealed osteoporotic changes both in the patients and the carriers.
CONCLUSION: The findings demonstrate that OPPG carriers have reduced bone mass, which is a risk factor for development of early osteoporotic changes.
OBJECTIVE: To measure bone density in two siblings with the OPPG syndrome as well as in their family members (parents and siblings).
METHODS: Bone mineral density was determined in the lumbar spine (antero-posterior), femoral neck, two-thirds distal forearm (> 95% cortical bone) and ultradistal forearm (predominantly trabecular bone) by dual-energy X-ray absorptiometry.
RESULTS: The studies revealed osteoporotic changes both in the patients and the carriers.
CONCLUSION: The findings demonstrate that OPPG carriers have reduced bone mass, which is a risk factor for development of early osteoporotic changes.
Предметные рубрики MeSH
Abnormalities, MultipleAbsorptiometry, PhotonAdolescentAdultBlindnessBone DensityCase-Control StudiesChromosomes, Human, Pair 11ConsanguinityForearmGenes, RecessiveHeterozygoteHumansIsraelJewsLDL-Receptor Related ProteinsLow Density Lipoprotein Receptor-Related Protein-5Lumbar VertebraeMaleMutationOsteoporosisPedigreeReceptors, LDLRisk FactorsSeizuresSyndromeTunisia